GLP-1 Obesity Support Expanded by Vitality

Discovery Vitality is expanding GLP-1 obesity support as demand for anti-obesity medicines continues to rise among South African medical scheme members. The rewards programme says medication alone may not deliver lasting results. It is therefore adding doctor-led assessments to its HealthyWeight programme, alongside existing diet and exercise support. The assessment may result in a prescription for anti-obesity medication where clinically…

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in